Abstract

Ribosome biogenesis is a multi-step process, in which a network of trans-acting factors ensures the coordinated assembly of pre-ribosomal particles in order to generate functional ribosomes. Ribosome biogenesis is tightly coordinated with cell proliferation and its perturbation activates a p53-dependent cell-cycle checkpoint. How p53-independent signalling networks connect impaired ribosome biogenesis to the cell-cycle machinery has remained largely enigmatic. We demonstrate that inactivation of the nucleolar SUMO isopeptidases SENP3 and SENP5 disturbs distinct steps of 40S and 60S ribosomal subunit assembly pathways, thereby triggering the canonical p53-dependent impaired ribosome biogenesis checkpoint. However, inactivation of SENP3 or SENP5 also induces a p53-independent checkpoint that converges on the specific downregulation of the key cell-cycle regulator CDK6. We further reveal that impaired ribosome biogenesis generally triggers the downregulation of CDK6, independent of the cellular p53 status. Altogether, these data define the role of SUMO signalling in ribosome biogenesis and unveil a p53-independent checkpoint of impaired ribosome biogenesis.

Ribosome biogenesis is tightly coordinated with cell-cycle progression. By characterizing the SUMO isopeptidases SENP3/SENP5, Doenig et al. identify a long-sought p53-independent impaired ribosome checkpoint that converges on downregulation of CDK6.

Details

Title
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis
Author
Dönig, Judith 1 ; Mende, Hannah 1 ; Davila Gallesio, Jimena 2 ; Wagner, Kristina 1 ; Hotz, Paul 1   VIAFID ORCID Logo  ; Schunck, Kathrin 3 ; Piller, Tanja 4   VIAFID ORCID Logo  ; Hölper, Soraya 4 ; Uhan, Sara 5 ; Kaulich, Manuel 1   VIAFID ORCID Logo  ; Wirth, Matthias 6   VIAFID ORCID Logo  ; Keller, Ulrich 5   VIAFID ORCID Logo  ; Tascher, Georg 1   VIAFID ORCID Logo  ; Bohnsack, Katherine E. 2   VIAFID ORCID Logo  ; Müller, Stefan 7   VIAFID ORCID Logo 

 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721) 
 University Medical Centre Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331) 
 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); PharmBioTec gGmbH, Schiffweiler, Germany (GRID:grid.7839.5) 
 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Sanofi AG, Frankfurt, Germany (GRID:grid.420214.1) 
 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Max Delbrück Center, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849) 
 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Max Delbrück Center, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); University Medical Center Göttingen, Department of General, Visceral and Pediatric Surgery, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331) 
 Goethe University Frankfurt, Medical Faculty, Institute of Biochemistry II, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
Pages
8121
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2899558589
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.